Your browser doesn't support javascript.
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic.
Gasmi, Amin; Noor, Sadaf; Tippairote, Torsak; Dadar, Maryam; Menzel, Alain; Bjørklund, Geir.
  • Gasmi A; Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
  • Noor S; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University Multan, Pakistan.
  • Tippairote T; Nutritional and Environmental Medicine Department, BBH Hospital, Bangkok, Thailand; Faculty of Medicine, Ramathibodi Hospital and Institute of Nutrition, Mahidol University, Bangkok, Thailand.
  • Dadar M; Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
  • Menzel A; Laboratoires Réunis, Junglinster, Luxembourg.
  • Bjørklund G; Council for Nutritional and Environmental Medicine (CONEM), Mo i Rana, Norway. Electronic address: bjorklund@conem.org.
Clin Immunol ; 215: 108409, 2020 06.
Article in English | MEDLINE | ID: covidwho-50980
ABSTRACT
It is an ugly fact that a significant amount of the world's population will contract SARS-CoV-II infection with the current spreading. While a specific treatment is not yet coming soon, individual risk assessment and management strategies are crucial. The individual preventive and protective measures drive the personal risk of getting the disease. Among the virus-contracted hosts, their different metabolic status, as determined by their diet, nutrition, age, sex, medical conditions, lifestyle, and environmental factors, govern the personal fate toward different clinical severity of COVID-19, from asymptomatic, mild, moderate, to death. The careful individual assessment for the possible dietary, nutritional, medical, lifestyle, and environmental risks, together with the proper relevant risk management strategies, is the sensible way to deal with the pandemic of SARS-CoV-II.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Risk Management / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: English Journal: Clin Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: J.clim.2020.108409

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Risk Management / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: English Journal: Clin Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: J.clim.2020.108409